Journal article
Oxantel disrupts polymicrobial biofilm development of periodontal pathogens
S Dashper, N O'Brien-Simpson, SW Liu, R Paolini, H Mitchell, K Walsh, T D'Cruze, B Hoffmann, D Catmull, Y Zhu, E Reynolds
Antimicrobial Agents and Chemotherapy | Published : 2014
DOI: 10.1128/AAC.01375-13
Abstract
Bacterial pathogens commonly associated with chronic periodontitis are the spirochete Treponema denticola and the Gramnegative, proteolytic species Porphyromonas gingivalis and Tannerella forsythia. These species rely on complex anaerobic respiration of amino acids, and the anthelmintic drug oxantel has been shown to inhibit fumarate reductase (Frd) activity in some pathogenic bacteria and inhibit P. gingivalis homotypic biofilm formation. Here, we demonstrate that oxantel inhibited P. gingivalis Frd activity with a 50% inhibitory concentration (IC50) of 2.2 μM and planktonic growth of T. forsythia with a MIC of 295 μM, but it had no effect on the growth of T. denticola. Oxantel treatment ca..
View full abstractGrants
Funding Acknowledgements
This research was partially supported by an International Association for Dental Research/Glaxo-Smith Kline Innovation in Oral Care Award.